People · Operator
Named in public records as an officer, director or promoter · active 2020–2026 · Other, Healthtech, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Positive Development, Inc. | — | Other | Series B | $72.2M | $119.7M | 2020 |
| Daymark Health, Inc. | — | Healthtech | Series B | $37.5M | $122.2M | 2025 |
| Mindoula Health, Inc. | — | Healthtech | Series B | $30.7M | $662.6M | 2020 |
| Sonarmd, Inc. | — | Other Health Care | Series A | $10.5M | $8.0M | 2026 |
Roy Beveridge at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Roy Beveridge on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Manish Agarwal | 1 | 9 |
| Brenton Fargnoli | 1 | 7 |
| John Banta | 1 | 6 |
| Ambar Bhattacharyya | 1 | 6 |
| Alon Krashinsky | 1 | 6 |
| Mark Pacala | 1 | 5 |
| Adam Seabrook | 1 | 5 |
| Navid Farzad | 1 | 4 |
| Robert Pahlavan | 1 | 3 |
| THOMAS M SHEHAB | 1 | 2 |
| Kelsey Maguire | 1 | 2 |
| Aman Mahajan | 1 | 2 |
| Matt Bettonville | 1 | 2 |
| Daniel Gebremedhin | 1 | 2 |
| Brian Lovett | 1 | 2 |
| Robert Haft | 1 | 2 |
| Paul Dufault | 1 | 1 |
| Beth Houck | 1 | 1 |
| Paul Default | 1 | 1 |
| Jonathan Rhodes | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.